Hitachi And Redlen Technologies Announce Agreement On Joint Development
March 7, 2016
Saanichton, BC, — Hitachi Medical Corporation, a subsidiary of Hitachi, Ltd. (TSE:6501) and Redlen Technologies Inc., a Canadian technology company, today announced an agreement to jointly develop a direct conversion semiconductor x-ray detector module required for new photon counting computed tomography systems (PCCT), a promising next generation diagnostic medical imaging modality.
Hitachi has been focusing on the healthcare field as one of the Social Innovation Business, and has extensive expertise in healthcare total solutions which include medical diagnostic and clinical devices such as CT, MRI, particle beam therapy systems, and also informatics including medical service and platform. Redlen is a leading manufacturer of high resolution Cadmium Zinc Telluride (CZT) semiconductor radiation detectors which are used in the fields of medical imaging, security and nondestructive testing.
Author: Redlen Technologies
In the news
Yaletown Partners was proud to work closely with one of our Portfolio Companies, GoBolt, in their recent announcement of raising m…
December 7, 2022
Yaletown Partners is thrilled to be featured in the 2022 edition of The 50: A Guide to the Canadian Venture Capital Ecosystem, a c…
November 17, 2022